Korean Stock
EXCH
Vaxcell-Bio Therapeutics
★
Investor Relations Meeting
 05/18/2026, 04:56 PM
PERI
Vaxcell-Bio Therapeutics
★
VaxCell-Bio Q1 2026: Revenue 1.54B Won, Operating Loss 4.62B Won; Pipeline Progress and Distribution Business Stabilization
 05/15/2026, 05:02 PM